Hôpital François Mitterand

Dijon 21000

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma, B-Cell

Studies at this site

• Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma — Withdrawn before enrolling